<SUBMISSION>
<SECRELEASE-DATETIME> 20240415-172421 ⇐ Metadata from SEC Info (ET)
<SECWEBSITE-DATETIME> 20240415-172415 ⇐ Metadata from SEC Info (ET)
<ACCEPTANCE-DATETIME> 20240415-172326 ⇐ Filing accepted by SEC (ET)
<ACCESSION-NUMBER> 0001193125-24-096391
<TYPE> PRE 14A
<PUBLIC-DOCUMENT-COUNT> 3
<PERIOD> 20240606
<FILING-DATE> 20240415
<DATE-OF-FILING-DATE-CHANGE> 20240415
|
<FILER>
<COMPANY-DATA>
<CONFORMED-NAME> Alaunos Therapeutics, Inc.
<CIK> 0001107421
<ASSIGNED-SIC> 2834
<ORGANIZATION-NAME> 03 Life Sciences
<IRS-NUMBER> 841475642 ⇒ 84-1475642
<STATE-OF-INCORPORATION> DE
<FISCAL-YEAR-END> 1231
</COMPANY-DATA>
<FILING-VALUES>
<FORM-TYPE> PRE 14A
<ACT> 34
<FILE-NUMBER> 001-33038
<FILM-NUMBER> 24845521
</FILING-VALUES>
<BUSINESS-ADDRESS>
<STREET1> 2617 BISSONNET ST
<STREET2> SUITE 225
<CITY> HOUSTON
<STATE> TX
<ZIP> 77005
<PHONE> (346) 355-4099
</BUSINESS-ADDRESS>
<MAIL-ADDRESS>
<STREET1> 2617 BISSONNET ST
<STREET2> SUITE 225
<CITY> HOUSTON
<STATE> TX
<ZIP> 77005
</MAIL-ADDRESS>
<FORMER-COMPANY>
<FORMER-CONFORMED-NAME> ZIOPHARM ONCOLOGY INC
<DATE-CHANGED> 20050919
</FORMER-COMPANY>
<FORMER-COMPANY>
<FORMER-CONFORMED-NAME> EASYWEB INC
<DATE-CHANGED> 20010213
</FORMER-COMPANY>
</FILER>
|
<DOCUMENT>
<TYPE> PRE 14A
<SEQUENCE> 1
<FILENAME> d778708dpre14a.htm
<DESCRIPTION> PRE 14A
<TEXT>
<HTML>
Show <HTML>: 5,659 lines (widest: 270 characters) - 507K bytes
</TEXT>
</DOCUMENT>
|
<DOCUMENT>
<TYPE> GRAPHIC
<SEQUENCE> 2 ⇐ Not a Document/Exhibit
<FILENAME> g778708g01g01.jpg
<DESCRIPTION> GRAPHIC
<TEXT>
Show <TEXT>: 5,422 lines (Unix-to-Unix encoding) - 326K bytes
</TEXT>
</DOCUMENT>
|
<DOCUMENT>
<TYPE> GRAPHIC
<SEQUENCE> 3 ⇐ Not a Document/Exhibit
<FILENAME> g778708g02g02.jpg
<DESCRIPTION> GRAPHIC
<TEXT>
Show <TEXT>: 3,633 lines (Unix-to-Unix encoding) - 216K bytes
</TEXT>
</DOCUMENT>
|
</SUBMISSION> |
| ↑Top |
